164 related articles for article (PubMed ID: 28025970)
21. Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients.
Tanaka T; Ihara M; Fukuma K; Yamamoto H; Washida K; Kimura S; Kada A; Miyata S; Miyata T; Nagatsuka K
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680932
[TBL] [Abstract][Full Text] [Related]
22. Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients.
Oscanoa TJ; Guevara-Fujita ML; Fujita RM; Muñoz-Paredes MY; Acosta O; Romero-Ortuño R
Br J Clin Pharmacol; 2024 Mar; 90(3):769-775. PubMed ID: 37940132
[TBL] [Abstract][Full Text] [Related]
23. The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis.
Sermsathanasawadi N; Sritongsathian C; Pongrattanaman N; Praditsuktavorn B; Hongku K; Wongwanit C; Ruangsetakit C; Chinsakchai K; Mutirangura P; Poungvarin N
J Med Assoc Thai; 2015 Jun; 98(6):549-54. PubMed ID: 26219158
[TBL] [Abstract][Full Text] [Related]
24. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
[TBL] [Abstract][Full Text] [Related]
25. A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.
Wei M; Ye F; Xie D; Zhu Y; Zhu J; Tao Y; Yu F
Thromb Haemost; 2012 Jun; 107(6):1083-91. PubMed ID: 22534826
[TBL] [Abstract][Full Text] [Related]
26. Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis.
Liang R; Wang C; Zhao H; Huang J; Hu D; Sun Y
Thromb Res; 2012 Jul; 130(1):38-44. PubMed ID: 22192158
[TBL] [Abstract][Full Text] [Related]
27. VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts).
Chertovskikh YV; Malova EU; Maksimova NR; Popova NV; Sychev DA
Int J Risk Saf Med; 2015; 27 Suppl 1():S17-8. PubMed ID: 26639691
[TBL] [Abstract][Full Text] [Related]
28. VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients.
Chua YA; Abdullah WZ; Yusof Z; Gan SH
Turk J Med Sci; 2015; 45(4):913-8. PubMed ID: 26422867
[TBL] [Abstract][Full Text] [Related]
29. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Brandão LR; Ito S
Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
[TBL] [Abstract][Full Text] [Related]
30. Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors.
Lu Y; Yang J; Zhang H; Yang J
Clin Pharmacokinet; 2013 Jul; 52(7):567-81. PubMed ID: 23515956
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.
Wang F; Guo J; Zhang A
J Cardiovasc Pharmacol; 2019 Mar; 73(3):127-135. PubMed ID: 30688796
[TBL] [Abstract][Full Text] [Related]
32. Effect of CYP2C9-VKORC1 interaction on warfarin stable dosage and its predictive algorithm.
Li X; Liu R; Yan H; Tang J; Yin JY; Mao XY; Yang F; Luo ZY; Tan SL; He H; Chen XP; Liu ZQ; Li Z; Zhou HH; Zhang W
J Clin Pharmacol; 2015 Mar; 55(3):251-7. PubMed ID: 25187307
[TBL] [Abstract][Full Text] [Related]
33. [Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].
Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Konovalova NV; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(6):59-65. PubMed ID: 21786578
[TBL] [Abstract][Full Text] [Related]
34. VKORC1 and CYP2C9 genotype distribution in Asian countries.
Gaikwad T; Ghosh K; Shetty S
Thromb Res; 2014 Sep; 134(3):537-44. PubMed ID: 24908449
[TBL] [Abstract][Full Text] [Related]
35. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
Ghozlan MF; Foad DA; Darwish YW; Saad AA
Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
[TBL] [Abstract][Full Text] [Related]
36. The influence of CYP2C9 and VKORC1 gene polymorphisms on optimal warfarin doses after heart valve replacement.
Tatarūnas V; Lesauskaitė V; Veikutienė A; Jakuška P; Benetis R
Medicina (Kaunas); 2011; 47(1):25-30. PubMed ID: 21681008
[TBL] [Abstract][Full Text] [Related]
37. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
[TBL] [Abstract][Full Text] [Related]
38. The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population.
Dilge Taşkın B; Kula S; Ergün MA; Altun D; Olguntürk R; Tunaoğlu FS; Oğuz AD; Gürsel T
Anatol J Cardiol; 2016 Oct; 16(10):791-796. PubMed ID: 27182616
[TBL] [Abstract][Full Text] [Related]
39. Value of VKORC1 (-1639G>A) rs9923231 genotyping in predicting warfarin dose: A replication study in South Indian population.
Harikrishnan S; Koshy L; Subramanian R; Sanjay G; Vineeth CP; Nair AJ; Nair GM; Sudhakaran PR
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S110-S115. PubMed ID: 30595241
[TBL] [Abstract][Full Text] [Related]
40. Association between VKORC1 gene polymorphism and warfarin dose requirement and frequency of VKORC1 gene polymorphism in patients from Kerman province.
Soltani Banavandi MJ; Satarzadeh N
Pharmacogenomics J; 2020 Aug; 20(4):574-578. PubMed ID: 31902949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
